Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 2
2019 2
2020 9
2021 6
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for qingpu gong
Search for Qingfa Gong instead (1 results)
[Drug resistance and molecular typing of diarrheagenic escherichia coli from the diarrhea clinics in Qingpu District, Shanghai].
Shi YR, Yu X, Hu Y, Ma SW, Lu XY, Gong X, Xu QF. Shi YR, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Jul 3;57:65-71. doi: 10.3760/cma.j.cn112150-20221129-01159. Online ahead of print. Zhonghua Yu Fang Yi Xue Za Zhi. 2023. PMID: 37400221 Chinese.
Objective: To analyze the drug resistance and multilocus sequence typing of five types of diarrheagenic Escherichia coli (DEC) isolated from diarrhea outpatients of diarrhea comprehensive monitoring designated hospital in Qingpu District, Shanghai from 2015 to 2019. Method …
Objective: To analyze the drug resistance and multilocus sequence typing of five types of diarrheagenic Escherichia coli (DEC) isolated from …
[Drug resistance and molecular typing of diarrheagenic escherichia coli from the diarrhea clinics in Qingpu District, Shanghai City from 2015 to 2019].
Shi YR, Yu X, Hu Y, Ma SW, Lu XY, Gong X, Xu QF. Shi YR, et al. Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Aug 6;57(8):1199-1205. doi: 10.3760/cma.j.cn112150-20221129-01159. Zhonghua Yu Fang Yi Xue Za Zhi. 2023. PMID: 37574313 Chinese.
Objective: To analyze the drug resistance and multilocus sequence typing of five types of diarrheagenic Escherichia coli (DEC) isolated from diarrhea outpatients of diarrhea comprehensive monitoring designated hospital in Qingpu District, Shanghai City from 2015 to 2019. M …
Objective: To analyze the drug resistance and multilocus sequence typing of five types of diarrheagenic Escherichia coli (DEC) isolated from …
Asthma treatment adherence and related factors in Shanghai, China.
Du J, Shi YH, Duan YX, Wang XR, Zhou M, Gu WC, Wen CJ, Gong Y, Du CL, Peng B, Sun L, Tang W. Du J, et al. Chin Med J (Engl). 2021 Sep 23;134(20):2506-2508. doi: 10.1097/CM9.0000000000001680. Chin Med J (Engl). 2021. PMID: 34561319 Free PMC article. No abstract available.
Prevalence and risk factors of diabetic retinopathy among Chinese adults with type 2 diabetes in a suburb of Shanghai, China.
Tan H, Wang X, Ye K, Lin J, Song E, Gong L. Tan H, et al. PLoS One. 2022 Oct 4;17(10):e0275617. doi: 10.1371/journal.pone.0275617. eCollection 2022. PLoS One. 2022. PMID: 36194621 Free PMC article.
BACKGROUND: To investigate the prevalence and risk factors of diabetic retinopathy (DR) in a Chinese population with type 2 diabetes mellitus (T2DM) in a suburb (Qingpu) of Shanghai, China. METHODS: A population-based cross-sectional study. A total of 7462 residents with T …
BACKGROUND: To investigate the prevalence and risk factors of diabetic retinopathy (DR) in a Chinese population with type 2 diabetes mellitu …
Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial.
Yu XF, Zhu XY, Yuan CX, Wu DH, Zhao YW, Yang JJ, Wang CD, Wu WW, Liu XY, Liu ZG, Nie ZY, Deng BQ, Bao H, Li LX, Wang CY, Zhang HZ, Zhang JS, Huang JH, Gong F, Wang MZ, Guo YM, Sun Y, Cai DF. Yu XF, et al. Chin J Integr Med. 2022 Dec;28(12):1063-1071. doi: 10.1007/s11655-022-3586-8. Epub 2022 Oct 17. Chin J Integr Med. 2022. PMID: 36251140 Clinical Trial.
37 results